C M Gulhati

Rediff.com » News » C M Gulhati

News for C M Gulhati

Business

Pharma majors under fire over trial compensation

A Union health ministry probe has revealed that pharmaceutical majors conducting clinical trials in India have not given compensation to majority of the volunteers who died during the trials.Of the......

Anti-obesity drug may be banned

Over 20 drug companies marketing anti-obesity drug sibutramine under a variety of brand names are likely to soon face a ban on selling the medicine. The apex drug regulator, Drugs Controller......

India emerges as drug testing hub

In an indication of India's growing importance as a clinical trial destination, multinational pharmaceutical firms are queuing up for approvals to test their new drugs here. At least a dozen global......

Pharma firms bank on brand extensions

Stiff competition in a highly fragmented market has led the domestic drug makers to depend on brand extensions rather than new product launches to corner a market share. A market intelligence......

Pharma firms bent rules to hike prices: Study

An investigation carried out by the Indian edition of the leading medical bulletin, the Monthly Index of Medical Specialties, has found that several drug companies, including leading pharmaceutical......

Rediff News

C M Gulhati

News for C M Gulhati

Pharma majors under fire over trial compensation

Anti-obesity drug may be banned

India emerges as drug testing hub

Pharma firms bank on brand extensions

Pharma firms bent rules to hike prices: Study

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS